Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07189182 · ClinicalTrials.gov registry record · Early Phase 1
Clinical Evaluation of the Origin Intubation System
A Early Phase 1 study, sponsored by Stanford University.
- Not yet
- Registry status
- Early Phase 1
- Development phase
- 15
- Enrollment target
NCT07189182: Clinical Trial Early Phase 1 study, sponsored by Stanford University.
NCT07189182 is a Early Phase 1 study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07189182, a Early Phase 1 study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
There are currently two options that are utilized are artificial airways in the operating room as well in emergency medicine: the endotracheal tube and the supraglottic airway. However, with these devices, healthcare professionals often experience difficulty and/or failure in utilizing these devices during their first-pass at intubation. Additionally, military medics often forego intubation in favor of basic life support during prolonged resuscitation. This study aims to test a device, one that has been tested in over 100 cadavers, to determine if it is a viable and safer/more successful option for intubation.
Interventions
- DEVICE Origin Intubation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2026-09-01 |
| Est. Completion | 2027-09-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07189182
The ClinicalTrials.gov registry entry for NCT07189182 describes a study currently listed as not yet recruiting, categorized as Early Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Origin Intubation System is the first listed.
NCT07189182 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07189182 about?
NCT07189182 is a clinical study titled "Clinical Evaluation of the Origin Intubation System". There are currently two options that are utilized are artificial airways in the operating room as well in emergency medicine: the endotracheal tube and the supraglottic airway. However, with these devices, healthcare professionals often experience difficulty and/or failure in utilizing these devices...
What is the current status of trial NCT07189182?
This trial is currently not yet recruiting. It is a Early Phase 1 study. The enrollment target is 15 participants. The study started on 2026-09-01. Estimated completion is 2027-09-01.
What interventions are being tested in trial NCT07189182?
The interventions under investigation include: Origin Intubation System (DEVICE).
Who is sponsoring clinical trial NCT07189182?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.